HealthEquity, Inc. (NASDAQ:HQY) major shareholder Berkley Capital, Llc sold 286,512 shares of the firm’s stock in a transaction that occurred on Thursday, October 5th. The shares were sold at an average price of $51.96, for a total transaction of $14,887,163.52. The sale was disclosed in a filing with the SEC, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Berkley Capital, Llc also recently made the following trade(s):

  • On Monday, October 9th, Berkley Capital, Llc sold 1,100 shares of HealthEquity stock. The shares were sold at an average price of $51.95, for a total transaction of $57,145.00.
  • On Friday, October 6th, Berkley Capital, Llc sold 29,032 shares of HealthEquity stock. The shares were sold at an average price of $51.97, for a total transaction of $1,508,793.04.
  • On Friday, July 14th, Berkley Capital, Llc sold 72,791 shares of HealthEquity stock. The shares were sold at an average price of $51.41, for a total transaction of $3,742,185.31.

Shares of HealthEquity, Inc. (NASDAQ HQY) traded down 0.04% during midday trading on Wednesday, reaching $51.32. 293,380 shares of the company traded hands. The company has a 50 day moving average price of $46.41 and a 200 day moving average price of $46.70. The company has a market capitalization of $3.10 billion, a PE ratio of 76.14 and a beta of 1.80. HealthEquity, Inc. has a 1-year low of $30.34 and a 1-year high of $54.95.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.13. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business had revenue of $56.90 million for the quarter, compared to analyst estimates of $55.66 million. During the same quarter in the prior year, the business posted $0.16 EPS. HealthEquity’s revenue for the quarter was up 28.7% compared to the same quarter last year. On average, analysts expect that HealthEquity, Inc. will post $0.71 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “HealthEquity, Inc. (HQY) Major Shareholder Berkley Capital, Llc Sells 286,512 Shares” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/11/healthequity-inc-hqy-major-shareholder-berkley-capital-llc-sells-286512-shares.html.

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in HealthEquity by 6.2% during the 1st quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock valued at $174,691,000 after purchasing an additional 240,136 shares in the last quarter. Paloma Partners Management Co acquired a new position in HealthEquity during the 1st quarter valued at approximately $503,000. First Trust Advisors LP increased its stake in HealthEquity by 17.0% during the 2nd quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock valued at $4,698,000 after purchasing an additional 13,676 shares in the last quarter. Royce & Associates LP increased its stake in HealthEquity by 18.0% during the 2nd quarter. Royce & Associates LP now owns 139,200 shares of the company’s stock valued at $6,936,000 after purchasing an additional 21,200 shares in the last quarter. Finally, Russell Investments Group Ltd. acquired a new position in HealthEquity during the 2nd quarter valued at approximately $1,362,000. Institutional investors and hedge funds own 90.97% of the company’s stock.

Several brokerages recently weighed in on HQY. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a research report on Wednesday. BidaskClub raised shares of HealthEquity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. Cantor Fitzgerald raised their price target on shares of HealthEquity from $55.00 to $56.00 and gave the company an “overweight” rating in a research report on Wednesday, July 5th. Robert W. Baird reissued a “hold” rating on shares of HealthEquity in a research report on Thursday, September 21st. Finally, TheStreet raised shares of HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $57.17.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.